Aptus Value Housing Finance schedules investor meet on June 05
Aptus Value Housing Finance India Ltd has scheduled an investor and analyst meeting on June 05, 2026, in Mumbai, pursuant to SEBI LODR Regulation 30. The meetings will include one-on-one and group sessions based on publicly available information, with no unpublished price sensitive information to be shared.

*this image is generated using AI for illustrative purposes only.
Aptus Value Housing Finance India Ltd has scheduled an investor and analyst meeting on June 05, 2026, in Mumbai. The meetings will be conducted on a one-on-one basis and in group settings as part of an investor conference. The company stated that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) is intended to be shared during the session.
The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also informed that the Investor Presentation has been uploaded on its website and was intimated to the Stock Exchanges via a letter dated May 06, 2026.
Sanin Panicker, Company Secretary & Compliance Officer, signed the disclosure on June 03, 2026. The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company.
| Event Detail | Information |
|---|---|
| Event Type | Investor/Analyst Meeting |
| Date | June 05, 2026 |
| Location | Mumbai |
| Format | One-on-one and Group Meetings |
| Regulation | SEBI LODR Regulation 30 |
Historical Stock Returns for Aptus Value Housing Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.89% | +0.99% | +1.49% | -6.57% | -13.78% | -23.52% |
What key growth drivers or strategic initiatives is Aptus Value Housing Finance likely to emphasize during the investor meeting?
How might the outcomes of these meetings influence investor sentiment or stock performance in the near term?
What are the potential market or regulatory challenges that could impact Aptus's business outlook post-discussions?


































